In the BioHarmony Drug Report Database

"Preview" Icon

Amoxapine

Asendin, Adasuve (amoxapine) is a small molecule pharmaceutical. Amoxapine was first approved as Asendin on 1982-01-01. It is used to treat depressive disorder, psychophysiologic disorders, and psychotic affective disorders in the USA. It has been approved in Europe to treat bipolar disorder and schizophrenia. The pharmaceutical is active against sodium-dependent serotonin transporter and sodium-dependent noradrenaline transporter. In addition, it is known to target 5-hydroxytryptamine receptor 6, 5-hydroxytryptamine receptor 2C, 5-hydroxytryptamine receptor 7, and 5-hydroxytryptamine receptor 2A.

 

Trade Name

 

Adasuve
 

Common Name

 

amoxapine
 

ChEMBL ID

 

CHEMBL1113
 

Indication

 

bipolar disorder, depressive disorder, psychophysiologic disorders, psychotic affective disorders, schizophrenia
 

Drug Class

 

Tricyclic compounds

Image (chem structure or protein)

Amoxapine structure rendering